MEDISPA.PRO
Ministry of Health code: A11.01.003 Axis M4 · Musculoskeletal system and kinesiotherapy CEBM: Level B (Injection methods)

Platelet-rich plasma injections (PRP, plasmolifting)

Platelet-Rich Plasma (PRP) Injections

Industry clinical and economic procedure passport. Full biological mechanism (MoA), patient preparation protocol, first-choice equipment fleet, integration into the resort's master treatment rooms and market price benchmarks.

Session duration
40 min
Turnover: ~55 min
Recommended course
3 sessions
3 treatments – an assumption for the economic calculation; the course is prescribed by a physician
Throughput capacity
9 pts
per 8-hour shift
Median rate
9 200 ₽
8 162 ₽ – 23 325 ₽
Course cost
27 600 ₽
at market median
Publication volume
Level B
6 publ. in PubMed

Clinical profile

Injection of a platelet concentrate from the patient's own blood into a joint, tendon or skin. Meta-analyses show clinically significant improvement in knee osteoarthritis (better than placebo and hyaluronic acid) and in plantar fasciitis; for tendinopathies and alopecia the evidence is of low quality.

Every statement links to a publication in the list below. This is a snapshot of published research, not a final assessment of the method: international practice and integrated protocols often run ahead of official publications. Draft based on published research; requires review by a physician. Revision: 2026-10-17.

Where studies show an effect

  • Knee osteoarthritis: clinically significant improvement in function up to 12 months and pain reduction at 3–6 months versus placebo. [1]
  • In knee osteoarthritis, PRP gives better results than hyaluronic acid. [2]
  • Plantar fasciitis: greater pain reduction than after corticosteroids, shockwave therapy and placebo. [3]
  • Lateral epicondylitis: injection therapy with autologous blood and PRP is effective. [6]

Open questions and study limitations

  • Tendinopathies: effect comparable to other ultrasound-guided injections; evidence of low and very low quality. [4]
  • Alopecia: evidence of benefit is limited and mostly of low quality. [5]
  • In plantar fasciitis, the advantage does not hold for all outcome measures. [3]

Safety

  • Injection-site pain is more common than after other ultrasound-guided injections. [4]

Protocol in studies

  • In knee osteoarthritis, the effect depends on platelet concentration. [1]
  • Leucocyte-poor PRP may be preferable in knee osteoarthritis. [2]
Contraindications. Contraindications are determined by the physician according to the equipment or drug instructions; they are not given in study abstracts.

Equipment fleet and fit-out

Certified first-choice medical equipment and compatible device systems

Equipment registry
Base configuration (Hero Device)
Laboratory centrifuge, PRP tubes

Device platform with proven validation of the biological response. Includes built-in biofeedback sensor systems, patient protection protocols and precision dosing of exposure.

Certification: Russian Ministry of Health registration certificate / CE Medical Device Directive Class IIa/IIb.
Compatible platforms in the MEDISPA.PRO registry
Laboratory centrifuge
Medical device, Roszdravnadzor registration certificate / CE
In the registry →
PRP tubes
Medical device, Roszdravnadzor registration certificate / CE
In the registry →

Architectural integration and treatment rooms

Resort rooms housing the treatment station (with SanPiN norms and MEP loads)

All treatment rooms →

Unit economics and resort price benchmarks

Market analysis based on a sample of premium sanatoriums, wellness hotels and preventive medicine clinics

Market price corridor
25th percentile (P25) 8 162 ₽
Market median 9 200 ₽
75th percentile (P75) 23 325 ₽

Median of prices in industry facilities' price lists, 2026

Basis of the price benchmark

Prices for this procedure appear in the price lists of 6 industry facilities; the median and interquartile range across facilities are shown (each facility counts once).

Evidence base

Meta-analyses of RCTs show benefit in knee osteoarthritis and plantar fasciitis; for other indications the evidence is of low quality.

Publication level B · Some data
  1. 1.
    PRP Injections for the Treatment of Knee Osteoarthritis: The Improvement Is Clinically Significant and Influenced by Platelet Concentration: A Meta-analysis of Randomized Controlled Trials.
    Am J Sports Med, 2025 · Meta-analysis · PMID 39751394
    Knee osteoarthritis: clinically significant improvement in function up to 12 months and in pain at 3–6 months versus placebo; platelet concentration matters.
  2. 2.
    Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Am J Sports Med, 2021 · Systematic review and meta-analysis of RCTs · PMID 32302218
    Knee osteoarthritis: results better than after hyaluronic acid; leucocyte-poor PRP may be preferable.
  3. 3.
    Platelet rich plasma therapy versus other modalities for treatment of plantar fasciitis: A systematic review and meta-analysis.
    Foot Ankle Surg, 2024 · Systematic review and meta-analysis · PMID 38395675
    Plantar fasciitis: less pain than after corticosteroids, ESWT and placebo; the advantage does not hold for all outcomes.
  4. 4.
    Ultrasound-guided injection of platelet-rich plasma for tendinopathies: a systematic review and meta-analysis.
    Blood Transfus, 2023 · Systematic review and meta-analysis · PMID 36346880
    Tendinopathies: effect comparable to other injections, low-quality evidence; injection-site pain is more common.
  5. 5.
    Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis.
    Blood Transfus, 2023 · Systematic review and meta-analysis · PMID 34967722
    Alopecia: evidence of benefit is limited and mostly of low quality.
  6. 6.
    Treatment Options for Tennis Elbow - An Umbrella Review.
    Folia Med Cracov, 2023 · Umbrella review · PMID 38310528
    Lateral epicondylitis: autologous blood and PRP injections are effective.

Publications were found in PubMed; titles and journals are given verbatim, conclusions are a brief summary of the abstracts under the conditions of the specific studies. The level shows the volume of published data, not the value of the method: A — Plenty of data: consistent systematic reviews and meta-analyses of RCTs; B — Some data: reviews or several RCTs, results are heterogeneous; C — Little data: single RCTs or controlled studies; D — Scarce data: mainly reviews, observational and experimental studies. The passport is updated as new work is published and with regard to international practice.